New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (Obinutuzumab) for Primary Membranous Nephropathy (pMN). Click here for more information. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Katherine Torres

Coordinator, Fundraising & Development

Katherine serves as NephCure’s Fundraising and Development Coordinator, supporting the team across donor engagement, acknowledgments, and cultivation to ensure our incredible donors feel the appreciation and care they deserve. She plays a critical role in growing our community of supporters and strengthening the relationships that make our work possible, helping implement thoughtful stewardship efforts across the organization.

Based in San Antonio, Texas, Katherine brings valuable nonprofit experience and a strong background in donor relations. Her attention to detail, warmth, and passion for mission-driven work make her a wonderful addition to the team. Outside of work, she enjoys baking, going on walks, and spending time with her two chihuahuas.

San Antonio, TX

Related News

NEWS

The FDA Grants Accelerated Approval of ULTOMIRIS (ravulizumab-cwvz) for Adults with IgA Nephropathy 

NEWS

NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.